Radiotherapy in triple-negative breast cancer: Current situation and upcoming strategies
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference34 articles.
1. Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy;Abdulkarim;J. Clin. Oncol.,2011
2. Patterns and risk factors of locoregional recurrence in T1-T2 node negative breast cancer patients treated with mastectomy: implications for postmastectomy radiotherapy;Abi-Raad;Int. J. Radiat. Oncol. Biol. Phys.,2011
3. Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199;Adams;J. Clin. Oncol.,2014
4. Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer;Anders;Clin. Breast Cancer,2009
5. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation;Bartelink;N. Engl. J. Med.,2001
Cited by 83 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Development of CuO and CuO:Zn2+ nano-oxides for dye degradation and pharmaceutical studies;Inorganic Chemistry Communications;2024-02
2. Activation of autophagy promotes the inhibitory effect of curcumin analog EF‐24 against MDA‐MB‐231 cancer cells;Journal of Biochemical and Molecular Toxicology;2024-01-19
3. Protein disulfide isomerase family member 4 promotes triple-negative breast cancer tumorigenesis and radiotherapy resistance through JNK pathway;Breast Cancer Research;2024-01-02
4. Advancements and hurdles in the development of a vaccine for triple-negative breast cancer: A comprehensive review of multi-omics and immunomics strategies;Life Sciences;2024-01
5. Evolutionary Profil of Triple-Negative Breast Cancer and Influence of Histopronostic Factors: Experience of Oncology Department Chu Ibn Rochd Casablanca;European Journal of Medical and Health Sciences;2023-12-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3